Efficacy and Safety of NestaCell® in Huntington's Disease

计划入组 120 人 · 首次发布于 2023 年 10 月 24 日

NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia

计划入组 90 人 · 首次发布于 2020 年 3 月 20 日

Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zoster in Vulnerable Population Receiving ImmunOmodulaNt Therapies

计划入组 150 人 · 首次发布于 2026 年 4 月 16 日

X-Synergy®

NanoLithium® NP03

Integra®-SC

GENOMIC HEALTH, INC.

United States

Theralase Technologies Inc

Canada

Nextcell Pharma Ab

Denmark

Phase II Trial Shows NestaCell® Dental Pulp Stem Cell Therapy Significantly Improves Motor Function in Huntington's Disease Patients

ViroGates and Sobi Expand Collaboration on suPARnostic® Diagnostic for Kineret® Treatment

Novo Nordisk Launches NovoCare® Pharmacy, Offering Authentic Wegovy® at $499 Monthly